alexa Non Pathogenic Intestinal Protozoa | Switzerland| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relevant Topics

Non Pathogenic Intestinal Protozoa

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Non Pathogenic Intestinal Protozoa

    Prevention of the disease is by separating food and water from faeces and by proper sanitation measures. There is no vaccine. There are two treatment options depending on the location of the infection. If present in tissues is treated with either metronidazole, tinidazole, nitazoxanide, dehydroemetine or chloroquine, while luminal infection is treated with diloxanide furoate or iodoquinoline. The overall frequency of intestinal parasites was 65%. Entamoeba histolytica was detected by the coproantigen test, and the PCR showed that Entamoeba dispar predominated in the population. In contrast, morphometric analysis was important for identifying Entamoeba hartmanni.

  • Non Pathogenic Intestinal Protozoa

    Many intestinal protozoa parasites inhabit the gastrointestinal tract of humans. However, majority of them are non-pathogenic commensals or only result in mild disease while a few of them such as Cryptosporidium parvum (CP), Entamoeba histolytica (EH) and Giardia lamblia (GL) are pathogenic. Entamoeba histolytica serves as a paradigm for invasive colonic protozoal infection. The key to diagnosis and treatment of amebiasis is knowledge of the epidemiologic risk factors and clinical manifestations, a rational approach to diagnosis, and an understanding of the sites of action and uses of anti-amebic drugs.

Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings